Clinical Trials Browser

Phase 2 × Glioma × Fluorescein × Clear all

NCT02691923 2025-08-03

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Phase 2 Recruiting

Brain Neoplasms, Glioma